Phase 2 Peripheral Neuropathy Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with cancer that has been confirmed through laboratory testing of tissue samples
• People who have completed at least one round of chemotherapy treatment using a drug called albumin-bound paclitaxel
• People whose blood, liver, and kidney function results are within an acceptable range
• People who have developed nerve-related side effects (such as numbness, tingling, or pain) from chemotherapy, rated at a moderate level or higher using a standard medical scale
• Women who are able to become pregnant and have had a pregnancy test (urine or blood) within 3 days before starting the study
• People who are willing and able to attend all required visits, follow the treatment plan, and complete all study requirements

Who may not be able to join:

• People who already have a condition that raises the risk of nerve damage, such as diabetes, thyroid disease, a history of heavy alcohol use, a family history of nerve problems, or previous use of medications known to cause nerve damage
• People who are currently taking part in another clinical trial that involves a treatment or intervention (observational studies or follow-up phases of a previous trial may be acceptable — confirm with trial site)
• People who have taken any medication to treat or prevent nerve damage in the 2 weeks before screening, or who have received traditional Chinese medicine treatments (such as acupuncture, herbal medicine, moxibustion, or cupping) within the past month
• People with a known active tuberculosis (TB) infection
• People with a known active syphilis infection
• People with a known allergy to any ingredient in the study drug, including alcohol
• People with a known history of mental illness, drug dependence, or alcohol addiction
• People with any existing or current health condition, ongoing treatment, or abnormal test result that could affect the study results or make participation unsuitable (confirm with trial site)
• People with a serious non-cancer illness, or a cancer-related condition that significantly raises medical risk — for example, a very high white blood cell count or significant unexplained weight loss of more than 10% in the 3 months before screening
• People who are pregnant, breastfeeding, or planning to breastfeed during the study period
• People whom the trial investigators consider unsuitable for other reasons (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.